B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation - Wikidata - wikimedia - TriplyDB

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

http://www.wikidata.org/entity/Q34124940

about

B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look Nuclear envelope lamin-A couples actin dynamics with immunological synapse architecture and T cell activation.TU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: microbe-independent effects involving Akt and NF-κB suppression Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.The role of E3 ubiquitin ligase Cbl proteins in interleukin-2-induced Jurkat T-cell activation.Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors.CD25 and CD69 induction by α4β1 outside-in signalling requires TCR early signalling complex proteins.The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4.MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.The nature of activatory and tolerogenic dendritic cell-derived signal II.B7 family checkpoint regulators in immune regulation and disease.Challenges and new prospects in hepatosplenic γδ T-cell lymphoma.B7-H4 downregulation induces mitochondrial dysfunction and enhances doxorubicin sensitivity via the cAMP/CREB/PGC1-α signaling pathway in HeLa cells.Shikonin Suppresses Human T Lymphocyte Activation through Inhibition of IKK β Activity and JNK Phosphorylation Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.Tetraspanins CD9 and CD151 at the immune synapse support T-cell integrin signaling.B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients.Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.The Antitumor Effect of Xihuang Pill on Treg Cells Decreased in Tumor Microenvironment of 4T1 Breast Tumor-Bearing Mice by PI3K/AKT~AP-1 Signaling Pathway.

P2860

Q26824446-B6B64183-DF1B-47BC-8ACC-A37EFD441165 Q30621014-B40C3DE8-5E55-4F10-8EDC-2E8E7514CE4B Q33654829-0A585933-861F-4ED3-B3E1-929E708D0956 Q34227834-DA2FF979-CF4C-410D-802D-CA8AC74014B6 Q36303510-E1FD0FB1-CC42-4BAE-80A8-5ED812395B80 Q36754726-3AAC0DA9-57F2-4A5C-85A2-C04D314D3D7A Q37014649-DEB92F23-8B06-46D9-A2C2-A939C7D76F75 Q37111986-500C0D1D-BF53-4E13-AA68-340D64885C96 Q37501853-9724EF94-75C3-40C2-97F4-47C5EC29BB1C Q37719477-99B6420A-C77B-4AE9-88EF-C7B279F3BFCC Q38040302-15B0BAD5-17E2-4261-B7DA-D59E5530E0DD Q38085577-15AD66C4-BE59-46F2-A0B3-0137BC5B7547 Q38129635-656FF8B0-FAB5-4A0A-9290-9991FE1B52E2 Q38186104-8B51CDC4-F72D-4D4F-BF29-59F192C32567 Q39012736-2D770A80-2CE1-4BBA-AAC1-4F6A89B057CB Q41428122-2A636830-1E65-4CB8-8301-006061E13555 Q41701208-1ADFEBC1-967B-411C-97FC-25F7D094F7AD Q41896866-866F6746-2440-4FFD-B9C8-A4418C2F7EFA Q41932281-F7584C83-5DB0-4E57-BD70-FEE13D48C51E Q42636758-E84B44CC-A4A2-4C4C-BC48-D3665C46D0C6 Q55223364-D9496A0A-E232-4014-ABDD-D867528545DE

P2860

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

http://www.wikidata.org/entity/Q34124940

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@ast

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@en

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@nl

type

label

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@ast

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@en

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@nl

prefLabel

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@ast

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@en

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@nl

P1433

Q34124940-382016B8-1F00-4415-898C-5E6220BC3600

P1476

Q34124940-E5C56F3A-2CC7-4B47-B158-CBEBB1EA6A4B

P2093

Q34124940-34E619F8-B27C-4499-93DE-07D76DA844CA

Q34124940-3948AF76-85D3-4354-B531-24CB11B04248

Q34124940-58C76C2D-AB1B-4571-B337-555BDDE0B213

Q34124940-58DE5B9A-BE27-42E9-BBBA-E6A7D8338800

Q34124940-8BC96DBC-584E-437C-940A-C54D3A3C8C8E

Q34124940-92BC9C9A-6BF7-48BD-BBC8-63A6C3EBDF95

Q34124940-BC25AD27-F0F2-488D-B514-8EDD9F7245FD

Q34124940-D5092FAC-670A-4079-9DDD-4D5F5B208A6A

P2860

Q34124940-01DB9726-4F7C-46B0-82CE-E54AA7F1F11C

Q34124940-082974C5-77BE-4145-8480-C3636B60E7A4

Q34124940-0CA49B2D-B299-4E2D-8003-2EA8DC7F81C9

Q34124940-1508D86B-A4FB-4D43-B98E-D213D4598EFD

Q34124940-2132789F-5FDC-4898-B658-1F03DA107579

Q34124940-2508426C-DB4F-4A61-AAB0-8657A5D96C37

Q34124940-2AEFBBD0-EB2A-460E-99F9-51A085239C33

Q34124940-3A35603D-484F-43CA-8B12-599E5C3E618A

Q34124940-400A357D-BFF8-4CC8-8291-CC7892595E15

Q34124940-68B0F1E0-0615-4568-BA90-8C64BF34575C

P304

Q34124940-57BAD758-2F00-452C-845A-36607A636A95

P31

Q34124940-73F98564-3C5B-4588-BEAB-91F97F462986

P356

Q34124940-FEDA56CB-5215-4AAD-B8DB-CB1FF4607BE3

P407

Q34124940-0C50B594-EA5A-4E6D-BC41-3B1236ECB9B7

P433

Q34124940-E054083B-08C0-4B3C-B82D-B54D4476B9FF

P478

Q34124940-916A4853-982C-4210-A2A8-0E33EFC55C93

P50

Q34124940-5C9FCE2E-BDEA-434A-BADE-7B68FD0B3761

P577

Q34124940-431CDAF3-1B15-4747-8B35-2E23553CDB13

P5875

Q34124940-F9E1E763-7FEC-48FC-940E-11E47895CEEB

P698

Q34124940-0486EEA6-1CF1-419E-A9DF-76A32B5A30F9

P932

Q34124940-E2BB04C6-32A7-4DB0-BC7E-B0C3AE4DE08D

P356

JOURNAL.PONE.0028232

P1433

P1476

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

@en

P2093

Alice Mui

http://www.w3.org/2001/XMLSchema#string

C Bruce Verchere

http://www.w3.org/2001/XMLSchema#string

Dawei Ou

http://www.w3.org/2001/XMLSchema#string

Garth L Warnock

http://www.w3.org/2001/XMLSchema#string

Jianqiang Hao

http://www.w3.org/2001/XMLSchema#string

Lieping Chen

http://www.w3.org/2001/XMLSchema#string

Xiaojie Wang

http://www.w3.org/2001/XMLSchema#string

Ziliang Ao

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

B7x: a widely expressed B7 family member that inhibits T cell activation

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck

Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor

Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines.

Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Raf-1 is required for T cell IL2 production.

P304

e28232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0028232

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Daniel L Metzger

P577

2012-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221741525

http://www.w3.org/2001/XMLSchema#string

P698

22238573

http://www.w3.org/2001/XMLSchema#string

P932

3251556

http://www.w3.org/2001/XMLSchema#string